Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021). Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Advanced drug delivery reviews, 176, 113891. https://doi.org/10.1016/j.addr.2021.113891
Chicago Style (17th ed.) CitationXu, Xiaoyu, Chang Liu, Yonghui Wang, Oliver Koivisto, Junnian Zhou, Yilai Shu, and Hongbo Zhang. "Nanotechnology-based Delivery of CRISPR/Cas9 for Cancer Treatment." Advanced Drug Delivery Reviews 176 (2021): 113891. https://doi.org/10.1016/j.addr.2021.113891.
MLA (9th ed.) CitationXu, Xiaoyu, et al. "Nanotechnology-based Delivery of CRISPR/Cas9 for Cancer Treatment." Advanced Drug Delivery Reviews, vol. 176, 2021, p. 113891, https://doi.org/10.1016/j.addr.2021.113891.
Warning: These citations may not always be 100% accurate.